Powered by CloudAnalysis and the APPCenter, the APPsolute digital pathology offers a low cost, easy to budget solution for customers who need access to sophisticated image analysis capabilities for a specific amount of time.
The research involving 300 patients, showed that the speed, convenience, and cost structure provided by CloudAnalysis and Image APPs makes QDP an efficient, affordable, and attractive research tool.
CloudAnalysis allows instant access from work, home, or from anywhere to the complete suite of Visiopharm software solutions, including advanced image analysis and stereology.
The company said each Analysis Protocol Package (APP) includes detailed descriptions, references to scientific literature, illustrated examples, webinars, and more.
Visiopharm president Michael Grunkin said with its CloudAnalysis the upfront investment can be reduced to a fraction of any existing deployed solution.
Visiopharm provides Quantitative Digital Pathology solution for biopharmaceutical companies, clinical researchers, and academic researchers.